Investment Rating - The investment rating for Junting Hotel is not explicitly stated in the provided documents, but the report indicates a positive outlook on the company's strategic partnership and growth potential [1]. Core Viewpoints - Junting Hotel Group has entered a strategic partnership with Choice Hotels International, acquiring exclusive brand usage and franchise rights for the Comfort and Quality hotel brands in mainland China. This partnership allows Junting to leverage Choice's global distribution channels and marketing services [1][2]. - The Comfort brand has over 2,100 operating hotels and more than 170,000 rooms globally, while the Quality brand has over 2,000 operating hotels and more than 160,000 rooms. These brands are expected to compete effectively in the mid-to-high-end hotel market in China [2]. - The company is transitioning to a light-asset rapid expansion model, focusing on the mid-to-high-end hotel market through a joint venture, Junxing Hotel Management, which will initiate a franchise model [2]. - The strategic partnership is anticipated to enhance international customer acquisition, especially with the increasing popularity of inbound tourism in China, supported by favorable policies and a growing number of international travelers [3]. - Profit forecasts indicate that the net profit attributable to the parent company for 2024, 2025, and 2026 is expected to be 70 million, 99 million, and 151 million respectively, with corresponding price-to-earnings ratios of 59, 42, and 27 times [3]. Summary by Sections Strategic Partnership - Junting Hotel has secured exclusive rights for the Comfort and Quality brands in China, enhancing its market position and operational capabilities [1][2]. Market Position and Brand Strength - The Comfort and Quality brands are well-established globally, with significant numbers of operating hotels and rooms, positioning Junting to compete in the mid-to-high-end market [2]. Business Model Transition - The company is shifting towards a light-asset model and expanding through franchising, which is expected to accelerate growth and improve operational efficiency [2]. Inbound Tourism Potential - The strategic partnership is expected to capitalize on the rising trend of inbound tourism, with initiatives to attract international customers through membership collaboration [3]. Financial Projections - The financial outlook shows a steady increase in net profit over the next three years, indicating strong growth potential for the company [3].

Core Viewpoint - The partnership between Junting Hotels and Choice Hotels marks a significant shift for Junting as it moves away from its "small and beautiful" image towards a light-asset and scalable development model [1][2] Group 1: Partnership Details - Junting Hotels has entered into a long-term exclusive franchise agreement with Choice Hotels for the brands COMFORT™ and QUALITY™ in mainland China, lasting until 2045 [1] - Choice Hotels, despite having 7,500 hotels and approximately 650,000 rooms globally, has a limited presence in China, with its first hotel opening in 2002 [1][2] Group 2: Market Context - Major international hotel groups like InterContinental, Marriott, and Hilton have already established a strong presence in China, with over 500 new hotels opening in 2024 alone, totaling more than 4,500 hotels [2] - Wyndham Hotels, another franchise giant, has over 1,600 locations in China, highlighting the competitive landscape [2] Group 3: Strategic Implications - The collaboration allows Junting to overcome its expansion limitations while providing Choice Hotels with local market expertise to mitigate risks [2][3] - The partnership is seen as a "resource exchange," where Junting can leverage Choice Hotels' global network to transition from a regional brand to an international player [2] Group 4: Challenges Ahead - The partnership faces challenges due to the late entry of Choice Hotels into the Chinese market, requiring Junting to focus on localized operations to compete with established local brands [3] - Junting is under pressure to meet specific targets for opening and operating a designated number of hotels, with potential penalties for failing to do so [3] Group 5: Lessons from Success - The success of Hilton's HUALUXE brand serves as a valuable case study for mixed brands, demonstrating the importance of aligning with local consumer needs [5]

Investment Rating - Industry rating: Recommended [4] Core Insights - The report highlights a robust growth in visitor numbers during the Dragon Boat Festival, with a projected total of 6.87 billion trips, reflecting a year-on-year increase of 3.0% [1][18] - The demand for family-oriented travel has surged, particularly for short-distance self-driving trips and parent-child tours, with bookings for parent-child group tours increasing by 80% year-on-year [1][2] - The launch of new products by Lao Pu Gold, such as the Seven Sons Gourd, is expected to drive high demand in the fashion gold jewelry sector, despite a tightening overall consumption environment [2] Summary by Sections 1. Market Review - The consumer service index and retail index outperformed the CSI 300 index, with significant gains in the jewelry and watch sector [11] - The report notes a 5.1% year-on-year increase in total retail sales in April, with jewelry sales growing by 25.3% [36][50] 2. Industry & Company Dynamics - The report discusses the increase in domestic tourism, with various regions reporting significant visitor numbers during the holiday period [18][19] - Lao Pu Gold's new product launch is positioned to capture the growing trend in fashion jewelry, appealing to consumer sentiment and aesthetic preferences [2][3] 3. Macro & Industry Data - April's retail sales data indicates a stable growth trajectory, with online retail sales showing a 5.8% year-on-year increase [37] - The report provides insights into the gold jewelry market, noting a decline in overall gold consumption but an increase in gold bars and coins [52][55] 4. Investment Recommendations - The report suggests five investment themes, including the revival of traditional retail formats, the rise of AI technology applications, and the potential for new retail sectors to outperform expectations [59][61]

Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]

Core Viewpoint - Junting Hotel has signed a comprehensive franchise and distribution cooperation agreement with Choice Hotels Licensing, a wholly-owned subsidiary of Choice Hotels International, granting exclusive rights to use and franchise the COMFORT and QUALITY hotel brands in mainland China until December 31, 2045 [1] Group 1 - The development period of the agreement is from the effective date of the contract until December 31, 2045 [1] - Junting Hotel will integrate its first 68 hotels into Choice's global distribution channels, including Choice's website and mobile applications [1] - The agreement allows Junting Hotel to utilize distribution services provided by Choice Hotels [1]

证券代码：301073 证券简称：君亭酒店 公告编号：2025-016 君亭酒店集团股份有限公司 关于与 Choice Hotels Licensing B.V. 签订总特许经营及分销相关合作协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、君亭酒店集团股份有限公司（以下简称"公司"或"君亭酒店"）与精 选国际酒店集团（英文名：CHOICE HOTELS INTERNATIONAL, INC.，纽约证 券交易所代码：CHH，以下简称"精选国际"）全资子公司 Choice Hotels Licensing, B.V.（以下简称"Choice"）签署了总特许经营及分销相关合作协议，公司取得 Choice 旗下的 COMFORT（凯富）和 QUALITY（凯艺）两大酒店品牌系列在中 国大陆地区的独占品牌使用和特许经营权。另君亭旗下首批 68 家酒店接入 Choice 的全球分销渠道，包括 Choice 的网站及移动应用程序，并接受 Choice 提 供的分销服务（包括销售、营销、分销和预订服务和权利）。 2、协议的重大风险及重大不确定性：如 ...

Investment Rating - The report assigns a "Buy" investment rating for Junting Hotel (301073.SZ) [1][9] Core Views - The company is experiencing operational pressure during its ramp-up phase, with regional performance showing continued divergence [2] - The focus is on the progress of direct-operated stores and the acceleration of franchise expansion [3] - Profitability is expected to improve as the direct-operated business ramps up and the franchise model operates with lower asset intensity [4] Summary by Sections Financial Performance - In 2024, total revenue reached 676 million yuan, a year-on-year increase of 27%, while net profit attributable to shareholders was 25 million yuan, a decrease of 17% [1] - For Q1 2025, total revenue was 162 million yuan, a slight increase of 1%, but net profit dropped by 39% to 3 million yuan [1] Operational Metrics - In 2024, the company's occupancy rate (OCC), average daily rate (ADR), and revenue per available room (RevPAR) decreased by 4 percentage points, 1%, and 7% respectively [2] - For Q1 2025, OCC, ADR, and RevPAR further declined to 56.51%, 471.8 yuan, and 266.6 yuan, reflecting a more significant drop due to various economic pressures [2] Expansion Strategy - The company has invested in 11 new direct-operated hotels, with 10 already opened, and is focusing on the ramp-up speed and stable profitability of these new openings [3] - A joint venture, Junxing Hotel Management, was established in December 2024, and the franchise model is set to launch in 2025, covering major urban clusters [3] Profit Forecast - The company is projected to achieve earnings per share (EPS) of 0.38 yuan in 2025, with a corresponding price-to-earnings (P/E) ratio of 55 times [4][11] - Revenue is expected to grow from 777 million yuan in 2025 to 1,004 million yuan in 2027, with net profit forecasted to increase significantly in the coming years [11][12]

证券代码：301073 证券简称：君亭酒店 公告编号：2025-015 君亭酒店集团股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 一、 会议召开和出席情况 1、 召开时间：2025 年 5 月 22 日（星期四）14:30 6、 本次会议的召集、召开符合《中华人民共和国公司法》、《上市公司股东 会规则》、《深圳证券交易所创业板股票上市规则》等有关法律、行政法规、部门 规章、规范性文件和《君亭酒店集团股份有限公司章程》的有关规定。 二、 会议出席情况 （一）股东出席的总体情况 参加本次股东大会现场会议和网络投票表决的股东及股东代理人共 108 人， 代表股份 86,621,650 股，占上市公司总股份的 44.5468%。其中：通过现场投票 的股东 4 人，代表股份 86,120,450 股，占上市公司总股份的 44.2890%。通过网 络投票的股东 104 人，代表股份 501,200 股，占上市公司总股份的 0.2578%。 （二）中小股东出席的总体情况 参加本次股东大会现场会议和网络投票表决的中小 ...

下 天册律师事务所 法律意见书 浙江天册律师事务所 关于君亭酒店集团股份有限公司 2024 年年度股东大会的 法律意见书 编号:TCFGZY2025H0014 号 致:君亭酒店集团股份有限公司 浙江天册律师事务所(以下简称"本所")接受君亭酒店集团股份有限公司 (以下简称"君亭酒店"或"公司")的委托,指派本所律师参加公司 2024 年年 度股东大会,并根据《中华人民共和国证券法》(以下简称"《证券法》")、 《中华人民共和国公司法》(以下简称"《公司法》")和《上市公司股东会规 则》(以下简称"《股东会规则》")等法律、法规和其他有关规范性文件,以 及《君亭酒店集团股份有限公司章程》(以下简称"《公司章程》")的要求出具本 法律意见书。 在本法律意见书中,本所律师仅对本次股东大会召集、召开程序、出席人员 的资格、召集人的资格、表决程序及表决结果的合法有效性发表意见,不对会议 所审议的议案内容和该等议案中所表述的事实或数据的真实性和准确性发表意见。 本法律意见书仅供公司 2024年年度股东大会之目的使用。本所律师同意将本 法律意见书随君亭酒店本次股东大会其他信息披露资料一并公告,并依法对本所 在其中发表的法律 ...

国投证券股份有限公司 关于君亭酒店集团股份有限公司 （一）保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、 误导性陈述或重大遗漏，保荐机构及保荐代表人对其真实性、准确性、完整性 承担法律责任。 （二）本机构及本人自愿接受中国证监会对保荐总结报告书相关事项进行 的任何质询和调查。 首次公开发行股票并在创业板上市 持续督导保荐总结报告书 君亭酒店集团股份有限公司（以下简称"君亭酒店"或"发行人"）于 2021 年 9 月 30 日首次公开发行股票并在创业板上市。国投证券股份有限公司 （以下简称"国投证券"或"保荐机构"）担任君亭酒店首次公开发行股票并 在创业板上市的保荐机构，负责君亭酒店上市后的持续督导工作，持续督导期 至 2024 年 12 月 31 日。目前持续督导期限已经届满，根据《证券发行上市保荐 业务管理办法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市 公司自律监管指引第 2 号——创业板上市公司规范运作》等相关法规和规范性 文件的规定，保荐机构出具本保荐总结报告书。 一、保荐机构及保荐代表人承诺 （一）尽职推荐阶段 保荐机构及保荐代表人按照有关法律、行政法规和中国证监会的规定， ...